Ligocyte Pharmaceuticals Inc.

BOZEMAN, Montana, October 25, 2010 - LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.